Medicure (MCUJF) Liabilities and Shareholders Equity (2009 - 2026)
Medicure (MCUJF) posted quarterly Liabilities and Shareholders Equity of $17.0 million for Q1 2026, down 17.85% year-over-year from $20.8 million in Q1 2025, and down 4.71% quarter-over-quarter from $17.9 million in Q4 2025.
Medicure (MCUJF) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Medicure's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $17.0 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 17.85% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $74.9 million (down 10.38% YoY), while the FY2025 annual figure was $17.9 million, down 17.63% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $17.0 million, down from $17.9 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $23.5 million in Q2 2022, with the low at $17.0 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $21.1 million (2024), against an average of $20.9 million.
- The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity gained 3.08% in 2024, then decreased 17.85% in 2026.
- Medicure's Liabilities and Shareholders Equity stood at $22.0 million in 2022, then decreased by 6.43% to $20.6 million in 2023, then rose by 3.08% to $21.2 million in 2024, then retreated by 15.79% to $17.9 million in 2025, then dropped by 4.71% to $17.0 million in 2026.
- Business Quant data shows MCUJF's Liabilities and Shareholders Equity at $17.0 million in Q1 2026, $17.9 million in Q4 2025, and $19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 6.18 Bn |
| 10 | Medicure | 97.06 Mn | 95.93 Mn | 2.57 Mn | 17.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.05 Mn |
| Dec 31, 2025 | 17.89 Mn |
| Sep 30, 2025 | 19.42 Mn |
| Jun 30, 2025 | 20.51 Mn |
| Mar 31, 2025 | 20.75 Mn |
| Dec 31, 2024 | 21.25 Mn |
| Sep 30, 2024 | 20.89 Mn |
| Jun 30, 2024 | 20.64 Mn |
| Mar 31, 2024 | 21.28 Mn |
| Dec 31, 2023 | 20.61 Mn |
| Sep 30, 2023 | 21.52 Mn |
| Mar 31, 2023 | 21.72 Mn |
| Dec 31, 2022 | 22.03 Mn |
| Sep 30, 2022 | 22.97 Mn |
| Jun 30, 2022 | 23.46 Mn |
| Mar 31, 2022 | 22.28 Mn |
| Dec 31, 2021 | 22.54 Mn |
| Sep 30, 2021 | 23.97 Mn |
| Jun 30, 2021 | 25.16 Mn |
| Mar 31, 2021 | 25.16 Mn |